Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy.

Ma, Shoubao; Caligiuri, Michael A; Yu, Jianhua

Ma, Shoubao; Caligiuri, Michael A; Yu, Jianhua.

Afiliação

Ma S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA 91010, USA; Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Los Angeles, CA 91010, USA.
Caligiuri MA; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA 91010, USA; Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Los Angeles, CA 91010, USA; Comprehensive Cancer Center, City of Hope, Los Angeles, CA 91010, USA. Electronic address: mcaligiuri@coh.org.
Yu J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA 91010, USA; Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Los Angeles, CA 91010, USA; Comprehensive Cancer Center, City of Hope, Los Angeles, CA 91010, USA; Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Los Angeles, CA 91010, USA. Electronic address: jiayu@coh.org.

Trends Immunol ; 43(10): 833-847, 2022 10.

Article em En | MEDLINE | ID: mdl-36058806

Assuntos

Interleucina-15; Neoplasias; Citocinas; Humanos; Imunoterapia; Células Matadoras Naturais; Neoplasias/terapia

Palavras-chave

CAR NK cells; cancer immunotherapy; interleukin-15; natural killer cells

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-15 / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google